Intergroupe Francophone du Myelome (IFM) Phase III Study (IFM 2005 02) Evaluating Treatment with Continuous REVLIMID® ... (Business Wire via Yahoo! Finance)

Automated News - Automated News

User Rating: / 0
PoorBest 
BOUDRY, Switzerland----Celgene International Sàrl today announced that the Intergroupe Francophone du Myelome and University Hospital of Toulouse, the sponsor of the study, reported that the independent Data and Safety Monitoring Committee, of the international Phase III, randomized, double-blind, multi-center clinical study evaluating REVLIMID® compared to placebo in multiple myeloma patients ...

Read more: Yahoo! News Search Results for Multiple Myeloma

Comments (0)
Only registered users can write comments!

Users Online

We have 36 guests and 0 members online
No users online.

Recent Forum Topics

 

Myeloma Forums

Facebook Image

Social Bookmark

RSS Syndicator

Feed
Feed

Search Articles

Gallery Preview



Polls

How did you find us?
 

Polls

Did you have a Stem Cell Transplant?
 

Visitors Counter

mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday832
mod_vvisit_counterYesterday1259
mod_vvisit_counterThis week5958
mod_vvisit_counterLast week6803
mod_vvisit_counterThis month9913
mod_vvisit_counterLast Month28725
mod_vvisit_counterAll241993

Online (20 minutes ago): 25
Your IP: 38.107.191.83
,
Now is: 2010-09-09 16:09
JoomlaWatch Stats 1.2.9 by Matej Koval



Copyright © 2010 Myeloma Forums. - All Rights Reserved